Xeris Biopharma Holdings, Inc. (XERS)

NMS – Real vaqt narxi. Valyuta: USD

8.41

+0.02 (0.28%)

Bozor ochiq: Aug 12, 2026, 2:29 PM EDT

8.27

-0.12 (-1.43%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

07.08.2026

Xeris Biopharma Q2 Earnings Call Highlights

Xeris Biopharma NASDAQ: XERS reported second-quarter total revenue of $92.1 million, up 29% from a year earlier, as net product revenue increased 34% to $91 million. The company raised the low end of its full-year 2026 revenue outlook, now forecasting total revenue of $385 million to $390 million.

06.08.2026

Xeris Biopharma Holdings, Inc. (XERS) Q2 2026 Earnings Call Transcript

06.08.2026

Compared to Estimates, Xeris Biopharma (XERS) Q2 Earnings: A Look at Key Metrics

The headline numbers for Xeris Biopharma (XERS) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

06.08.2026

Xeris Biopharma Reports Second Quarter 2026 Financial Results

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced its financial results for the second quarter ended June 30, 2026. "The second quarter was another strong period for Xeris, with net product revenue growing 34% year-over-year, driven by Recorlev's exceptional commercial momentum,” said John Shannon,.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

Xeris Biopharma Holdings, Inc. (XERS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Q2 Earnings Call Highlights

Xeris Biopharma Holdings, Inc. (XERS) Q2 2026 Earnings Call Transcript

Compared to Estimates, Xeris Biopharma (XERS) Q2 Earnings: A Look at Key Metrics

Xeris Biopharma Reports Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

Xeris Biopharma Reports Second Quarter 2026 Financial Results

Xeris Biopharma Q2 Earnings Call Highlights

Xeris Biopharma Holdings, Inc. (XERS) Q2 2026 Earnings Call Transcript

Compared to Estimates, Xeris Biopharma (XERS) Q2 Earnings: A Look at Key Metrics

Xeris Biopharma Reports Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

Xeris Biopharma Reports Second Quarter 2026 Financial Results

Search stocks

Xeris Biopharma Holdings, Inc. (XERS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Q2 Earnings Call Highlights

Xeris Biopharma Holdings, Inc. (XERS) Q2 2026 Earnings Call Transcript

Compared to Estimates, Xeris Biopharma (XERS) Q2 Earnings: A Look at Key Metrics

Xeris Biopharma Reports Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

Xeris Biopharma Reports Second Quarter 2026 Financial Results

Xeris Biopharma Q2 Earnings Call Highlights

Xeris Biopharma Holdings, Inc. (XERS) Q2 2026 Earnings Call Transcript

Compared to Estimates, Xeris Biopharma (XERS) Q2 Earnings: A Look at Key Metrics

Xeris Biopharma Reports Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

Xeris Biopharma Reports Second Quarter 2026 Financial Results